Products - Adrenal dysfunction | Topic | NICE

Showing 4 products

Date | Title

Adrenal insufficiency: identification and management (NG243)
Product type:
Guidance
Programme:
NICE guideline
Published:
28 August 2024
Adrenal dysfunction
Status:
Awaiting development
Expected publication date:
TBC
Leriglitazone for treating andrenoleukodystrophy [ID3903]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Leriglitazone for treating X-linked andrenoleukodystrophy TS ID 9996
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC